Mirna Therapeutics
OTC: SYBXAustin, US · 4 known investors
Find your way into Mirna Therapeutics
90 people in our graph share verified history with the Mirna Therapeutics team — schools, employers, funds. One of them is your warm intro.
Chris Robinsonunlockedknows PAUL LAMMERS, MD, MSc · together at EMD Serono, Inc. (overlapped)
×8knows the team · via Radboud University
×3knows the team · via EMD Serono, Inc.
A Spanish-language blog that publishes articles on health and medicine topics, such as flu prevention and vaccination recommendations, for general readers.
Founders & leadership
MW
Matthew WinklerFounder
SK
Sinil KiminExecutive
PL
Paul LammersinExecutivePaul Lammers is an executive officer and director at Mirna Therapeutics with extensive experience in biopharmaceutical management across public and private companies. He has worked on therapeutics spanning women's and men's health, neurodegenerative diseases, metabolic disorders, orphan diseases, and oncology, and has served on boards of for-profit and non-profit organizations.
JI
Jon IrvinExecutive
CD
Casi DeYoungExecutive
Board
MP
Michael PowellBoard director
CG
Corey GoodmanBoard director
EM
EJ
Elaine JonesBoard director
CS
Clay SiegallBoard director
LA
Larry AllevaBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$121.8M disclosed across 2 rounds · 2015–2019
▶$80MraisedJun 2019 · 1 investors · BiotechnologyRule 506(b)
▶$80MraisedJun 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Edward MathersDirector
- Chau KhuongDirector
- Patricia HurterDirector
- Peter BarrettDirector
- Michael PowellDirector
- Aoife BrennanExecutive Officer, Director
- Nick LeschlyDirector
- Richard P. SheaDirector
- Todd ShegogExecutive Officer
- Offering amount
- $80M
- Amount sold
- $80M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$41.8MraisedMay 2015 · 24 investors · PharmaceuticalsRule 506(b)
▶$41.8MraisedMay 2015 · 24 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Matthew WinklerDirector
- Michael PowellDirector
- Clay SiegallDirector
- Sinil KimExecutive Officer
- Paul LammersExecutive Officer, Director
- Jon IrvinExecutive Officer
- Larry AllevaDirector
- Corey GoodmanDirector
- Casi DeYoungExecutive Officer
- Ed MathersDirector
- Elaine JonesDirector
- Offering amount
- $45M
- Amount sold
- $41.8M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Mirna Therapeutics do?
- A Spanish-language blog that publishes articles on health and medicine topics, such as flu prevention and vaccination recommendations, for general readers.
- Who founded Mirna Therapeutics?
- Mirna Therapeutics was founded by Matthew Winkler.
- Who are Mirna Therapeutics's investors?
- Mirna Therapeutics's investors include New Enterprise Associates (NEA), Pfizer Venture Investments, OrbiMed, OUP (Osage University Partners).
- How much funding has Mirna Therapeutics raised?
- Mirna Therapeutics has disclosed $121.8M raised across 2 rounds.
- Where is Mirna Therapeutics headquartered?
- Mirna Therapeutics is headquartered in Austin, US.